T分期即根据肿瘤大小进行分期，可将肺癌分为T1期（T1a、T1b、T1c）、T2期（T2a、T2b）、T3期和T4期。N分期即根据淋巴结转移位置进行分期，可将肺癌分为N1期、N2期、N3期。M分期即根据癌细胞远处转移情况进行分期，可将肺癌分为M1a、M1b、M1c期。此外，还包括Tx、Nx、Mx期和T
再看N 分期(M0 情况下) —— 若为 N1,任何 T1 或 T2 均归为 ⅡB 期;任何 T3 或 T4 均归为 ⅢA 期;若为 N2,任何 T1 或 T2 均归为 ⅢA 期;任何 T3 或 T4 均归为 ⅢB 期;若为 N3,任何 T1 或 T2 均归为 ⅢB 期;任何 T3 或 T4 均归为 ⅢC 期;若为 N0,则主要看 T。 最后看 T...
M1 有远处转移 分期 0期 Tis N0 M0 Ⅰ期 T1* N0 M0 ⅡA期 T0 N M0 T1 N1 M0 T2 N0 M0 ⅡB期 T2 N1 M0 T3 N0 M0 ⅢA期 T0 N2 M0 T1 N2 M0 T2 N2 M0 T3 N1 M0 T3 N2 M0 ⅢB期 T4 N0 M0 T4 N1 M0 T4 N2 M0 ⅢC期 任何T N3 M0 Ⅳ期 任何T 任何N M1 T1*包括T1mic...
199: Stereotactic Ablative Radiotherapy in T1-2n0m0 Small Cell Lung Cancer: A Systematic Review and Meta-AnalysisNon-small cell lung cancer (NSCLC)Locally advancedStereotactic ablative radiotherapy (SABR)Stereotactic body radiotherapy (SBRT)ToxicityLocal control...
In recent years, the treatment of limited stage small cell lung cancer has been stagnant, various treatments are poor. The operation is mainly suitable for patients with small cell lung cancer (T1-2N0M0). Small cell lung cancer has strong sensitivity to chemotherapy, but the clinical ...
Breast-conserving surgery (BCS) plus radiotherapy and mastectomy exhibit highly comparable prognoses for early-stage breast cancer; however, the safety of BCS for T1-2N3M0 breast cancer remains unclear. This study compared long-term survival for BCS versus (vs.) modified radical mastectomy (MRM) ...
- 1991 - 395 - www.sciencedirect.comdoi:10.1016/0169-5002(91)90432-6NoneELSEVIERLung Cancer
1, Bo Chen1, Ning-Ning Lu1, Shu-Lian Wang1* and Ye-Xiong Li1* Abstract Background: To compare the survival outcomes between breast-conserving surgery (BCS) and modified radical mastectomy (MRM), and to investigate the role of radiotherapy (RT) in patients with pT1–2N1M0 breast cancer...
The benefit of adjuvant chemotherapy (CT) for hormone receptor-negative T1a and T1bN0M0 breast cancer remains uncertain. Our study was to explore prognostic value and identify candidates of adjuvant CT for these patients. The data of hormone receptor-negative T1a and T1bN0M0 breast cancer patient...
第4、12、6、7、10、11组淋巴结癌转移率相对较高。有癌转移的淋巴结来自于35例患者, 占总例数的26.3%(35/133)。TMN分期0期(TisN0M0)5例, ⅠA期(T1aN0M0, T1bN0M0)93例, ⅡA期(T1aN1M0, T1bN1M0)9例, ⅢA期(T1N2M0)26例。 2. 3 临床病理特征与淋巴结转移的关系 肿瘤直径≤1 cm共19例...